Does Teladoc’s Stock Drop Matter? Jamey Edwards on Achieving Health Moonshots in the Face of Rocky Public Markets - podcast episode cover

Does Teladoc’s Stock Drop Matter? Jamey Edwards on Achieving Health Moonshots in the Face of Rocky Public Markets

May 03, 202229 min
--:--
--:--
Listen in podcast apps:

Episode description

This week’s episode of StartUp Health NOW is a conversation with Jamey Edwards, Chief Operating Officer at StartUp Health. Jamey has been working in the telemedicine space for more than a decade, and his last company, Cloudbreak, went public via SPAC last year. So when we saw the headlines that Teladoc's stock dropped 40% – alongside other dips in the telemedicine public market – we called him up for a dose of perspective. In this conversation with host Logan Plaster, Edwards breaks down the news from Wall Street and gives startups some health moonshot wisdom. Bottom line: stay focused on the mission because improving global health is a marathon, not a sprint. Entrepreneurs: How to get investment from StartUp Health startuphealth.com Investors: How to invest in StartUp Health Moonshots healthmoonshots.com Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.
Does Teladoc’s Stock Drop Matter? Jamey Edwards on Achieving Health Moonshots in the Face of Rocky Public Markets | StartUp Health NOW Podcast - Listen or read transcript on Metacast